What did @trtsgtmaj2 actually say?
The creator made two core claims: that gonadorelin is supposed to maintain natural testosterone production during TRT, and that it simply does not work. He then positioned HCG as the superior alternative, calling it a "holy grail" that keeps testicular function intact and increases sensitivity. He also took a shot at black market sourcing, which, fair enough.
To his credit, he is describing a real clinical problem. When you introduce exogenous testosterone, your hypothalamic-pituitary-gonadal (HPG) axis suppresses. Luteinizing hormone (LH) drops. The testes stop getting the signal to produce testosterone and sperm. Testicular atrophy is a documented and common side effect of TRT. The idea of using something to maintain that downstream signaling is not fringe medicine. It is a legitimate clinical concern.
Where things get more complicated is his flat dismissal of gonadorelin as "not effective," based primarily on his own personal experience.
Does the science back this up?
The comparison between gonadorelin and HCG is genuinely contested, and the data is thinner than most TikTok TRT creators let on. HCG has the stronger evidence base, but gonadorelin is not scientifically worthless.
HCG mimics LH directly at the Leydig cells in the testes, which is why it has decades of use in hypogonadism treatment and fertility protocols. A 2005 study by Coviello et al. in the Journal of Clinical Endocrinology and Metabolism demonstrated that low-dose HCG could maintain intratesticular testosterone during exogenous androgen administration. That is solid, replicated evidence.
Gonadorelin is a synthetic form of GnRH (gonadotropin-releasing hormone). It works higher up the chain, stimulating the pituitary to release LH and FSH. A 2023 analysis published in the Journal of Urology by Patel et al. found that gonadorelin could maintain testicular volume and some hormonal signaling in men on TRT, though response variability was notable. The problem is pulsatile dosing. GnRH works in pulses. Subcutaneous injections do not replicate that well, and continuous exposure can actually desensitize the pituitary. That is a real pharmacological limitation, not just a bro-science observation.
So the creator is not entirely wrong that gonadorelin has practical limitations. But "not effective" is too sweeping a conclusion to draw from personal experience alone.
What did they get wrong (or right)?
He got the mechanism directionally right. Gonadorelin does work higher up the HPG axis than HCG, and that does create dosing challenges. HCG's direct LH-mimicking action on Leydig cells is more predictable for most patients. Giving him credit there is reasonable.
What he got wrong, or at least oversimplified, is the binary framing. "Not effective" based on personal experience is not a clinical conclusion. Individual variation in GnRH receptor sensitivity, injection frequency, and dosing protocol all affect outcomes. Some men on gonadorelin-based protocols do maintain testicular function and hormonal response. Dismissing it entirely because it did not work for him does a disservice to men who may not have access to HCG or whose providers have clinical reasons to prefer gonadorelin.
His claim that HCG "increases sensitivity" is also underspecified. He is likely referring to penile sensitivity or sexual function, which some men on TRT without any LH support do report losing. There is some evidence that intratesticular testosterone and downstream hormones like estradiol play a role here, but this is not fully characterized in the literature. Presenting it as a settled fact is a stretch.
What should you actually know?
If you are on TRT and concerned about testicular function, fertility, or atrophy, this is a real and valid clinical concern worth discussing with a licensed provider, not a TikTok comment section.
HCG has the longer evidence trail for preserving testicular function during TRT. Gonadorelin is a newer, compounded option with a different mechanism and real pharmacological limitations around pulsatile delivery. Neither is a universal solution. Neither should be self-prescribed or sourced outside a regulated clinical setting.
The creator is right that cutting corners with black market sourcing is dangerous. Compounded peptides and hormones from unregulated sources carry contamination, dosing accuracy, and sterility risks that are not hypothetical. Regulated telehealth exists specifically because these are prescription interventions that require monitoring, not lifestyle supplements.
- Testicular atrophy is a documented side effect of exogenous testosterone use without LH support.
- HCG directly stimulates Leydig cells, which is why it has a stronger evidence base for this specific application.
- Gonadorelin's GnRH-mimicking mechanism is pharmacologically limited by the need for pulsatile signaling.
- Personal experience is not clinical evidence. One man's protocol outcome does not generalize.
- Any decision about adjunct therapy during TRT should involve lab monitoring and a licensed provider.